Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF SEPTEMBER 09, 2021 SAM #7222
SOURCES SOUGHT

65 -- SARS-CoV-2 & Influenza A/B Nucleic Acid Test & Quality Control Kit.

Notice Date

9/7/2021 3:18:50 PM
 

Notice Type

Sources Sought
 

NAICS

325413 — In-Vitro Diagnostic Substance Manufacturing
 

Contracting Office

W40M USA HLTH CONTRACTING ACT JBSA FT SAM HOUSTON TX 78234-0000 USA
 

ZIP Code

78234-0000
 

Solicitation Number

W81K00-21-Q-0273
 

Response Due

9/10/2021 10:00:00 AM
 

Archive Date

09/25/2021
 

Point of Contact

Medina L. Woodson, Phone: 2105398525, Fax: 2102213446, Randall P. Cummins, Phone: 719-526-5329, Fax: 719-524-5405
 

E-Mail Address

medina.l.woodson.civ@mail.mil, randall.p.cummins.civ@mail.mil
(medina.l.woodson.civ@mail.mil, randall.p.cummins.civ@mail.mil)
 

Description

Sources Sought Notice - Influenza A/B & COVID-19 Combination Testing The Regional Health Contracting Office - Central is issuing this Sources Sought Notice on behalf of San Antonio Military Medical Center, JBSA - Fort Sam Houston, Texas. Any responses to this Sources Sought Notice will be used for planning purposes only. This notice is not a solicitation of binding offers, nor is it a notice to proceed. The San Antonio Military Medical Center (SAMMC) has a requirement for SARS-CoV-2 & Influenza A/B Combo Nucleic Acid Test (and the SARS-CoV-2 & Influenza A/B Quality Control Kits) for FY22 through FY25. Vendors that consider themselves capable of providing the required testing are invited to submit a capability statement for the Government to consider via email to the Point of Contact listed herein. This capability statement shall include the following information. If the capability statement does not address ALL of the points below, the vendor will not be considered as capable of providing the required testing: 1.�� Vendor name (to include CAGE code and DUNS number); Point of Contact (to include email address and phone number); business size. 2.�� Documentation that demonstrates its ability to provide SARS-CoV-2 & Influenza A/B Combo Nucleic Acid Test (and quality control kits) testing. 3.��� Food and Drug Administration (FDA) approval if applicable. The SARS-CoV-2 & Influenza A/B Combo Nucleic Acid Test will allow the SAMMC to simultaneously detect COVID-19 and Influenza A and B strains in patients. With the looming overlap of the traditional influenza season and the ongoing COVID-19 pandemic, it is imperative that the laboratory has the ability to perform this diagnostic function for the identification of the below items for patient treatment. The response due date for this Sources Sought Notice is 12:00 PM CST,�10 September�2021. All questions and comments regarding this announcement shall be submitted via e-mail to the below POCs: See attached spreadsheet with the reagents�& quantity included.
 

Web Link

SAM.gov Permalink
(https://beta.sam.gov/opp/2174f4e039e84cc394bd43b506856716/view)
 

Place of Performance

Address: San Antonio, TX 78234-6200, USA

Zip Code: 78234-6200

Country: USA
 

Record

SN06124402-F 20210909/210907230132 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |